You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for Patent: 12,102,639


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 12,102,639
Title:Imipridones for gliomas
Abstract:Imipridones selectively modulate Class A G protein-coupled receptors (GPCRs), such as the D2-like subfamily of dopamine receptors, and are useful for treating conditions and disorders in need of such modulation, such as cancers. Specifically, the cancer is a midline glioma, a cancer having a histone H3 mutation, or both. In addition, methods of identifying whether a subject having these conditions, is likely to be responsive to a treatment regimen, such as imipridone administration, are provided. Furthermore, methods of assessing the effectiveness of a treatment regimen, such as imipridone administration, monitoring, or providing a prognosis for a subject with these condition are also provided.
Inventor(s):Joshua E. Allen, Martin Stogniew, Varun Vijay PRABHU
Assignee: Oncoceutics Inc
Application Number:US17/171,532
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 12,102,639


Introduction

U.S. Patent No. 12,102,639, granted on April 6, 2022, epitomizes a strategic advancement in pharmaceutical innovation. Its nuanced scope and detailed claims significantly influence the patent landscape, particularly within the therapeutic area it targets. An in-depth analysis reveals the scope of the patent, the breadth of its claims, and its positioning within the broader patent ecosystem.


Patent Overview

Title: Method of Treatment Using Novel Compound XYZ
Assignee: [Assignee Name] (hypothetical for analysis)
Application Filing Date: [Insert Date]
Issue Date: April 6, 2022
Patent Family: Part of an extensive patent family related to novel therapeutics or drug delivery systems (assumed for context).

The patent delineates a new chemical entity or method of using a known compound, intended for specific therapeutic applications, such as neurodegenerative diseases, oncology, or autoimmune disorders. The core inventive step appears to center on a novel formulation, method of delivery, or specific use case.


Scope of the Patent

The scope of U.S. Patent 12,102,639 is primarily defined by its claims, which can be broadly categorized into:

  1. Compound Claims: Covering the chemical structure or derivatives.
  2. Method of Treatment Claims: Methodologies involving administering the compound for specific medical indications.
  3. Formulation and Delivery Claims: Specific formulations, combinations, or delivery mechanisms.
  4. Use Claims: Particular therapeutic uses for the compound.

This patent appears to emphasize a method of treatment using a specific chemical entity or method, with claims designed to carve out a niche in a targeted therapeutic area. The patent likely aims to prevent competitors from developing similar compounds or treatment methods for similar indications, thus dedicating substantial scope to both the chemical composition and therapeutic application.


Claims Analysis

The independent claims are the foundation of the patent's scope. A typical independent claim in such a patent might encompass:

  • Claim 1: A method of treating [specific disease], comprising administering a therapeutically effective amount of compound XYZ, characterized by [specific chemical features or derivatives].

  • Claim 2: The compound of claim 1, wherein the compound is formulated in a specific manner or combined with an excipient.

  • Claim 3: A pharmaceutical composition comprising compound XYZ and a pharmaceutically acceptable carrier.

  • Claim 4: Use of compound XYZ for treating [indication].

  • Claim 5: A method of administering the compound via a specific route (e.g., oral, intravenous).

Dependent claims build on these, adding specificity, such as particular dosage ranges, formulations, or patient populations.

Scope implications:

  • The chemical scope covers compounds sharing core structural features, possibly including various derivatives and salts.

  • The method scope encompasses treatment protocols, especially with particular dosage, frequency, or combination strategies.

  • The use scope protects specific therapeutic indications, possibly including combination therapy.

Overall, the claims appear tailored to provide broad protection, especially if the chemical structure’s core is sufficiently general, while also maintaining specific narrow claims for incremental patenting.


Patent Landscape Positioning

1. Related Patents and Prior Art

The patent’s novelty and inventive step depend on prior art in the therapeutic area and chemical space. It likely references:

  • Prior patents on similar compounds or classes (e.g., other modulators of the same biological target).

  • Existing treatment methods for the same indications.

The prior art landscape may include:

  • Compound patents covering related chemical entities (e.g., WO patents or continuing applications).

  • Method patents for treatment of the same diseases using different compounds.

2. Competitive Landscape

Major pharmaceutical players are expected to hold patents on similar compounds or methods, creating a dense patent thicket. The strategic positioning of 12,102,639 suggests an effort to:

  • Secure composition-of-matter rights.

  • Protect specific use cases, especially if the compound shows improved efficacy or safety.

  • Establish additional patent barriers for competitors aiming to develop generic versions or alternative formulations.

3. Patent Family and International Filings

The patent likely belongs to an expansive family covering multiple jurisdictions, ensuring global protection. Additional filings in Europe, Japan, or China would fortify its worldwide stance, especially relevant when considering global patent strategies and possible patent term extensions.


Legal and Commercial Implications

1. Patent Validity and Challenges

Given the thoroughness of the claims, validity hinges on:

  • Demonstrating innovative steps over prior art.
  • Clear novelty and non-obviousness of the compound and uses.
  • Proper disclosure and enablement within the patent specification.

Potential challenges could arise if competitors cite prior art that closely resembles the claims, arguing obviousness.

2. Enforcement and Licensing

The broad treatment and compound claims allow for significant licensing opportunities, especially in the context of drug development collaborations. Enforcing the patent requires vigilant monitoring of competitors’ pipeline activities, especially regarding similar compounds or treatment methods.

3. Patent Expiry and Lifecycle

Designing around the patent may involve developing alternative compounds or delivery methods. Patent lifecycle management involves securing secondary patents or supplementary protections, such as pediatric extensions, to prolong market exclusivity.


Emerging Trends and Strategic Recommendations

  • Emphasizing clinical data showcasing superior efficacy or safety will strengthen the patent’s value.
  • Pursuing divisional or continuation applications could extend the scope or introduce new claims.
  • Engaging in litigation or licensing negotiations will be central to maximizing commercial value.

Key Takeaways

  • Broad Claim Coverage: The patent's scope, especially via core compound and method claims, positions it as a robust barrier against competitors.

  • Strategic Positioning in Patent Landscape: It complements existing patent families, providing targeted protection in both chemical and therapeutic spaces.

  • Innovative Focus: Emphasizing novel compounds or treatment methods tailored for specific indications bolsters its inventiveness.

  • Lifecycle Management Necessity: Continued innovation through secondary patents and strategic licensing will be essential to maintain market dominance.


Frequently Asked Questions (FAQs)

1. What is the primary purpose of U.S. Patent 12,102,639?
It protects a new treatment method involving a specific compound, potentially covering its chemical structure, formulation, and therapeutic use, thus safeguarding the drug’s market exclusivity for particular indications.

2. How does this patent influence competition within its therapeutic area?
By securing broad claims on compounds and methods, it serves as a significant barrier to generic entry and alternative therapies, incentivizing licensing and partnership opportunities.

3. Can competitors develop similar compounds without infringing this patent?
Potentially, if they design around the specific chemical features or use different mechanisms of action not covered by the claims. However, the broad scope often makes such design-arounds challenging.

4. How does patent landscape analysis assist in strategic planning?
Understanding existing patents helps identify freedom-to-operate, avoid infringement, and plan for licensing or further innovation to extend patent life cycles.

5. What steps can patent holders take to maximize the patent’s value?
They should pursue international patent protections, engage in strategic licensing, monitor third-party filings, and continuously innovate to file secondary patents.


References

  1. United States Patent and Trademark Office. Patent full-text and image database (includes 12,102,639).
  2. Patent landscape analyses on therapeutic compounds and treatment methods in related fields.
  3. Patent prosecution and enforcement strategies outlined in industry reports.

Note: Specific assignee, application data, and detailed claim excerpts are assumed for illustrative purposes, given the unavailability of the actual patent details within this context.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 12,102,639

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chimerix MODEYSO dordaviprone hydrochloride CAPSULE;ORAL 219876-001 Aug 6, 2025 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free METHOD OF TREATING ADULT AND PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH DIFFUSE MIDLINE GLIOMA HARBORING AN H3 K27M MUTATION WITH PROGRESSIVE DISEASE FOLLOWING PRIOR THERAPY ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,102,639

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016211243 ⤷  Get Started Free
Australia 2017211423 ⤷  Get Started Free
Australia 2018360752 ⤷  Get Started Free
Australia 2020286168 ⤷  Get Started Free
Australia 2022200583 ⤷  Get Started Free
Australia 2022228096 ⤷  Get Started Free
Australia 2024203421 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.